Skip to main content

Evrysdi Prices, Coupons, Copay Cards & Patient Assistance

Evrysdi (risdiplam) is a member of the miscellaneous uncategorized agents drug class and is commonly used for Spinal Muscular Atrophy.

The cost for Evrysdi (0.75 mg/mL) oral powder for reconstitution is around $13,639 for a supply of 80 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Evrysdi is available as a brand name drug only, a generic version is not yet available. View generic Evrysdi availability for more details.

Evrysdi prices

Oral Powder For Reconstitution

0.75 mg/mL

Evrysdi oral powder for reconstitution

 from $13,638.99

for 80 milliliters
Quantity Per unit Price
80 milliliters $170.49 $13,638.99

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Evrysdi Coupons, Copay Cards and Rebates

Evrysdi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Evrysdi Co-pay Program

Eligible commercially insured patients may pay $0 per 30-day prescription with a savings of $25,000 per calendar year; program applies to drug costs.

Applies to:
Evrysdi
Number of uses:
Per prescription per calendar year

Form more information phone: 833-387-9734 or Visit website

Evrysdi Co-pay Program Rebate

Eligible commercially insured patients may request a rebate if they paid in full at the pharmacy for their prescription.

Applies to:
Evrysdi
Number of uses:
One rebate per prescription fill

Form more information phone: 800-636-0316 or Visit website

Patient Assistance & Copay Programs for Evrysdi

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Evrysdi (risdiplam) Oral Solution

More information please phone: 866-316-7263 Visit Website

Provider: Good Days Program

Eligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
  • Evrysdi (risdiplam) Oral Solution

More information please phone: 877-968-7233 Visit Website

Provider: Genentech Patient Foundation

Eligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Evrysdi (risdiplam) Oral Solution

More information please phone: 888-941-3331   or 866-422-2377   Visit Website

Provider: MySMA Support for Evrysdi

Eligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. FDA-approved diagnosis
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Evrysdi (risdiplam) Oral Solution

More information please phone: 833-387-9734 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.